User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Clinical trials of antidepressants: the hidden face: where locus of control appears to play a key role in depression outcome.

Primary tabs

Reynaert, Christine [UCL] Janne, Pascal [UCL] Vause, Mireille [UCL] Zdanowicz, Nicolas [UCL] Lejeune, Dominique [MGD]

It remains difficult to determine in what measure improvements observed in clinical trials of anti-depressants may be attributable to the psychological predispositions of the subjects. The present article focuses on the effect of a psychological variable, the Health Locus of Control, which measures the extent of a subject's belief that he is in control over his own health. The hypothesis is that depressed subjects whose locus of control is internal, i.e. who perceive themselves to be in control, rather than external, i.e. control perceived as being in others or just chance, will improve more markedly and consistently on the Hamilton Depression Rating Scale, across a number of clinical trials. Forty-nine depressive patients undergoing treatment with four different compounds were included, after a week's placebo run-in period, in a classical 42-day follow-up study comprising visits on days -7, 0, 10, 21; and 42. Interactions between the type of locus of control and the clinical course were investigated by MANOVA. Results show that with a classical design of clinical trials of antidepressants, locus of control plays a significant role if it is internal (P < 0.001) in consolidating the improvement process, and that this is true irrespective of type of antidepressant. The relationship between the concept of locus of control and placebo effect is discussed.

Document type Article de périodique (Journal article) – Clinical Trial, Journal Article, Randomized Controlled Trial
Access type Accès restreint
Publication date 1995
Journal information "Psychopharmacology" - Vol. 119, no. 4, p. 449-54 (1995)
Peer reviewed yes
issn 0033-3158
Publication status Publié
Affiliations UCL - MD/NOPS - Département de neurologie et de psychiatrie
UCL - (MGD) Service de médecine psychosomatique
MESH Subject Adult ; Antidepressive Agents - therapeutic use ; Depression - drug therapy ; Fluoxetine - therapeutic use ; Humans ; Internal-External Control ; Maprotiline - therapeutic use ; Paroxetine - therapeutic use ; Psychiatric Status Rating Scales ; Time Factors ; Treatment Outcome
Links
  1. Abramson LY, Seligman MEP, Teasdale JD (1978) Learned helplessness in humans: critique and reformulation. J Abnorma Psychol 87:49–74
  2. Abramson LY, Metalsky GI, Alloy LB (1989) Hopelessness depression: a theory-based subtype of depression. Psychol Rev 96:358–372
  3. APA (1987) Diagnostic and statistical manual of mental disorders, 3rd edn, revised (DSM-III-R). The American Psychiatric Association, Washington, DC
  4. Bech P, Malt UF, Dencker SJ, Ahlfors UG, Elgen K, Lewander T, Lundell A, Simpson GM and Lingjaerde O (1993) Scales for assessment of diagnosis and severity of mental disorders. Act Psychiatr Scand 372:3–87
  5. Benassi VA, Sweeney PD, Dufour CL (1988) Is there a relationship between locus of control orientation and depression? J Abnorm Psychol 97:357–367
  6. Castrogiovanni P, Maremmani I, Deltito JA (1989) Discordance of self-ratings versus observer ratings in the improvement of depression: role of locus of control and aggressive behaviour. Comp Psychiatry 30:231–235
  7. Endlich Eric, Depression and Attributions for Problems and Solutions in College Students, 10.2466/pr0.1989.65.1.131
  8. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–61
  9. Harrow M, Ferrante A (1969) Locus of control in psychiatric patients. Arch Gen Psychiatry 33:582–589
  10. Hoojer C, Zitman FG, Griez E, Van Tilburg W, Willemse A, Dinkgreve M, Att M (1991) The Hamilton depression rating scale (HDRS): changes in scores as a function of training and version used. J Affect Disord 22:21–29
  11. Kobasa SC, Maddi SR, Kahn S (1982) Hardiness and health: a prospective study. J Person Soc Psychol 42:168–77
  12. Lau RR (1988) Beliefs about control and health behaviour. In: Gochman D (ed.) Health behaviour: Emerging research perspectives. Plenum, New York
  13. Lau RR and Ware JE (1979) Refinements in the measurement of health-specific locus of control beliefs. Med Care 19:1147–1158
  14. O'Brien KP, Glaudin V (1988) Factorial structure and factor reliability of the Hamilton rating scale for depression. Acta Psychiatr Scand 78:113–120
  15. Reichlin S (1993) Neuroendocrine-immune interactions. N Engl J Med 329:1246–1253
  16. Reynaert C, Parent M, Mirel J, Janne P, Haazen L (1995) Moclobemide versus fluoxetine for a major depressive episode. Psychopharmacology (in press)
  17. Rotter Julian B., Generalized expectancies for internal versus external control of reinforcement., 10.1037/h0092976
  18. Seligman MEP (1975) Helplessness: on depression, development, and death. Freeman, San Francisco
  19. Stassen -HH; Delini-Stula -A; Angst -J (1993) Time course of improvement under antidepressant treatment: a survival-analytical approach. Eur-Neuropsychopharmacol 3:127–35
  20. Statistical Package for Social Sciences (1986) Library of Congress Cataloging-in-Publication Data Norusis M.J. (Marija J) 1948-SPSS/PC + SPSS Inc. Chicago
  21. Strudler Wallston Barbara, Wallston Kenneth A., Locus of Control and Health: A Review of the Literature, 10.1177/109019817800600102
  22. Wallston Kenneth A., Strudler Wallston Barbara, DeVellis Robert, Development of the Multidimensional Health Locus of Control (MHLC) Scales, 10.1177/109019817800600107
  23. Wallston KA, Wallston BS, Smith S, Dobbins CJ (1987) Perceived control and health. Curr Psychol Res Rev 6[1]:5–25
Bibliographic reference Reynaert, Christine ; Janne, Pascal ; Vause, Mireille ; Zdanowicz, Nicolas ; Lejeune, Dominique. Clinical trials of antidepressants: the hidden face: where locus of control appears to play a key role in depression outcome.. In: Psychopharmacology, Vol. 119, no. 4, p. 449-54 (1995)
Permanent URL http://hdl.handle.net/2078.1/24412